Yahoo
XETRA EUR

aap Implantate AG (AAQ1.DE)

1.3900 +0.0100 (+0.72%)
As of 1:17:16 PM GMT+1. Market Open.
Chart Range Bar
Loading chart for AAQ1.DE
  • Previous Close 1.3800
  • Open 1.3800
  • Bid 1.3500 x --
  • Ask 1.4300 x --
  • Day's Range 1.3500 - 1.4500
  • 52 Week Range 1.2600 - 2.3400
  • Volume 5,185
  • Avg. Volume 1,594
  • Market Cap (intraday) 20.587M
  • Beta (5Y Monthly) 0.31
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1900
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

aap Implantate AG develops, manufactures, and markets traumatology products for orthopedics in Germany and internationally. The company offers LOQTEQ, an anatomical plating system for the treatment of ankle, straight plates, knee, elbow, wrist, and shoulder. It also provides cannulated screws, as well as offers antibacterial silver coating technology and our magnesium-based implants. The company sells its products directly to hospitals, purchasing groups, and hospital groups through a network of distributors. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

www.aap.de

105

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/11/2026, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

AAQ1.DE
2.11%
DAX P (^GDAXI)
8.36%

1-Year Return

AAQ1.DE
4.14%
DAX P (^GDAXI)
10.17%

3-Year Return

AAQ1.DE
72.67%
DAX P (^GDAXI)
74.20%

5-Year Return

AAQ1.DE
66.90%
DAX P (^GDAXI)
65.01%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY21
Revenue 2.7M
Earnings --
Profit Margin 0.00%

Q2

FY11

Q4

FY11

Q1

FY19

Q1

FY21

0
2M
4M
6M
8M
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -22.36%

  • Return on Assets (ttm)

    -11.52%

  • Return on Equity (ttm)

    -31.09%

  • Revenue (ttm)

    12.21M

  • Net Income Avi to Common (ttm)

    -2.73M

  • Diluted EPS (ttm)

    -0.1900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    286k

  • Total Debt/Equity (mrq)

    48.55%

  • Levered Free Cash Flow (ttm)

    -466.5k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: